Pharma Pulse 7/1/24: How Can Incoming, Existing Executives Build a Sustainable Role?

With CEO Turnover Rising to Record Levels, How Can Incoming, Existing Executives Build a Sustainable Role?

A Q&A with Russell Reynolds’ Global Lead of CEO & Executive Transition Practice, Ty Wiggins, PhD.

FDA Approves New Drug Application for Tepylute to Treat Breast, Ovarian Cancer

Tepylute is a ready-to-dilute, injectable formula that reduces preparation time and enable dosing accuracy.

AI Frenzy Propels Stocks to Monster First Half

S&P 500 has climbed 15% despite reduced hopes for Federal Reserve interest-rate cuts.

Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 - ResearchAndMarkets.com

The "Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.

Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 Report Highlights:

• mRNA Cancer Vaccines in Clinical Trials: > 60 Vaccines
• Highest Phase of Clinical Trials: Phase III (2 Vaccine)
• mRNA Cancer Vaccine Clinical Trials Insight by Company, Country, Indication & Phase
• First Commercial mRNA Vaccine Approval Expected by 2029
• US & China Dominating mRNA Cancer Vaccines Clinical Trials: > 45 Vaccines
• mRNA Vaccines for Skin Cancer Dominating Trials: > 10 Vaccines

@fda on Threads

Caregivers: Your job can be challenging at times.

Our office of women’s health has resources to help you care for yourself and others:

Have news you want us to share in Pharma Pulse? Reach out to Social

Media Editor Miranda Schmalfuhs